Know someone who would benefit from FSD education?

Enter their email(s)

  • Novel Self-administered Therapies for HSDD:
    Update on Expanding the Armamentarium

    Activity Approved for CME Credit: .75 AMA PRA Category 1 Credits
    Release/Expiration dates: August 16, 2018/2019

    View the Webcast
  • Safety of Flibanserin in Women Treated with SSRI/SNRI Antidepressants: Results of a Randomized, Placebo-Controlled Study

    Activity Approved for CME Credit: .25 AMA PRA Category 1 Credits
    Release/Expiration dates: June 13, 2019/2020

    View the Webcast
  • Diagnosing and Managing HSDD from a Primary Care Perspective

    Activity Approved for CME Credit: .75 AMA PRA Category 1 Credits
    Release/Expiration dates: December 20, 2018/2019

    View the Webcast
  • Investigational Treatment Options for HSDD: New Avenues

    Activity Approved for CME Credit: .50 AMA PRA Category 1 Credits
    Release/Expiration dates: April 18, 2019/2020

    View the Webcast
  • Bremelanotide: A Novel Treatment for Female Hypoactive Sexual Desire Disorder

    Activity Approved for CME Credit: .75 AMA PRA Category 1 Credits
    Release/Expiration dates: February 7, 2019/2020

    View the Webcast
  • Her Experience with HSDD:
    In Her Own Words

    Activity Approved for CME Credit: .50 AMA PRA Category 1 Credits
    Release/Expiration dates: October 11, 2018/2019

    View the Webcast
  • HSDD:
    A Case Presentation

    Activity Approved for CME Credit: 1.0 AMA PRA Category 1 Credits
    Release/Expiration dates: August 30, 2018/2019

    View the Webcast

A CME-certified initiative committed to alleviating symptoms of Hypoactive Sexual Desire Disorder through education about screening, diagnosis, treatment and long-term management.

Membership is Free

To get the most out of this initiative, we strongly suggest that you become a PLUS member. Please use our convenient form below to register and start enjoying the benefits immediately.


* = required